Neurogene Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Neurogene Inc. has filed 747 SEC EDGAR filings since 25 Jun 2007

SEC filing history

Showing 76-100 of 744 matching filings.

Per page
25
Current page
4
ARS File 001-36327

ARS

Filing date
25 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36327

DEFA14A

Filing date
25 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36327

DEF 14A

Filing date
25 Apr 2025
Reporting date
25 Apr 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-88050

SCHEDULE 13G/A filing

Filing date
23 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-286057

EFFECT filing

Filing date
04 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-283561

424B3

Filing date
01 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-286057

UPLOAD filing

Filing date
31 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283561

EFFECT filing

Filing date
28 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-286057

S-3

Filing date
24 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-283561

POS AM

Filing date
24 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-286055

S-8

Filing date
24 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2025
Reporting date
13 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88050

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88050

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88050

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88050

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .